Corporate News 06-Aug-22
Board of ERIS Lifesciences recommends Interim Dividend
Of Rs.7.35 per share
ERIS Lifesciences announced that the Board of Directors of the Company at its meeting held on 05 august 2022, has recommended a Final dividend of Rs.7.35 per share (i.e.735%), subject to the approval of the shareholders.
Previous News
ERIS Lifesciences consolidated net profit rises 11.78% in the December 2021 quarter
( Results - Announcements 28-Jan-22 13:56 )
ERIS Lifesciences to table results
( Corporate News - 29-Oct-19 17:26 )
ERIS Lifesciences acquires Biocon Biologics' Nephrology and Dermatology biz
( Corporate News - 10-Nov-23 13:29 )
ERIS Lifesciences appoints director
( Corporate News - 06-Jan-21 12:54 )
Volumes jump at ERIS Lifesciences Ltd counter
( Hot Pursuit - 31-Jan-24 11:00 )
ERIS Lifesciences consolidated net profit rises 17.96% in the June 2019 quarter
( Results - Announcements 29-Jul-19 10:10 )
Volumes jump at ERIS Lifesciences Ltd counter
( Hot Pursuit - 29-Sep-23 14:30 )
Volumes soar at Hatsun Agro Product Ltd counter
( Hot Pursuit - 03-Jul-19 14:30 )
ERIS Lifesciences schedules board meeting
( Corporate News - 21-Jan-21 14:40 )
Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
( Corporate News - 09-Nov-23 09:15 )
Board of ERIS Lifesciences recommends interim dividend
( Corporate News - 12-Mar-20 15:40 )
Other Stories
Board of NRB Bearings recommends interim dividend
05-Oct-24 09:27
Refex Industries to hold EGM
05-Oct-24 09:26
Allcargo Terminals to hold EGM
05-Oct-24 09:26
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Back
Top
